Posts Tagged ‘medical device’

  Last week, Perficient announced that it purchased Rise Foundation, a pre-configured and enhanced version of Microsoft SharePoint, from Blue Rooster. Rise Foundation provides companies with an intranet solution that has the look and feel users expect in today’s digital world. In addition to the impressive UI, the solution enables companies to be more productive […]

  On September 24, 2015, the FDA issued a Warning Letter to a manufacturer and distributor of medical devices for several violations. While the issues at hand may not seem severe, they do put the public at risk and reduce the confidence that the FDA has in the organization. Plus, they are inviting unwanted scrutiny […]

  We recently talked about Argus Safety’s ability to able to uniquely identify cases. Today, we’ll touch upon how Oracle’s drug safety and pharmacovigilance system supports CAPA rule #3. 

  I recently read an article from McKinsey & Company about the digital revolution that needs to occur in order for the life sciences industry to be successful in today’s age. This is the same digital revolution that helped transform other industries, such as financial and retail. Like I mentioned in one of my previous blog […]

  In 2009, the cost for a consumer to sequence his or her genome was $49,000. It’s all the way down to $1,000 today. As the price continues to become more affordable, the frequency of the average Joe sequencing his genome will likely increase. However, many individuals are wary of the idea of knowing more […]

  These days, it appears as if most of the big contract research organizations (CROs) are using Siebel CTMS, Oracle’s clinical trial management system. In June of this year, I wrote about Quintiles’ use of Oracle Health Sciences applications, including Siebel CTMS. Now we’re talking about PPD, another top-5 CRO. 

  It seems like every other day we’re reading about pharmaceutical companies developing mobile apps, or at the very least, investing in companies that develop them. And that’s for good reason: They work. They help researchers learn about disorders. They help educate patients on their conditions and provide treatment recommendations. They help with patient adherence. […]

  I’m sitting at my desk thinking to myself: Why don’t I see many ads trying to recruit patients for clinical trials? “Many” is actually an overstatement. I rarely see them. Anywhere. And that’s a problem. I’m fairly healthy, but I have some issues. I’m slowing balding. I suffer from heartburn. Sometimes, I have debilitating […]

  One question we often get relates to disabling Oracle Clinical (OC) and Remote Data Capture (RDC) accounts. What happens to the OC/RDC accounts of users who separate from a company or roll off of a clinical trial? The answer is relatively simple, though not necessarily obvious, because the only way to tell if an […]

  Bayer. Then Abbott, Roche, and Lilly. And then the rest. Reputation Institute, a research and advisory firm that focuses on tackling and analyzing the reputation of companies worldwide, released its annual ranking of the most reputable pharmaceutical companies in the world. 

  You’ve heard that saying before, right? Okay, it’s slightly different than the original one, which refers to IBM (one of our partners, too). But it’s true: to our knowledge, no client has ever regretted their implementation of the Google Search Appliance (GSA) solution. In fact, it’s quite the contrary. We consistently hear positive feedback […]

  In case you missed the headlines in the last few days, the FDA issued a Warning Letter to Duchesnay over Kim Kardashian’s Instagram post promoting Diclegis, the pharmaceutical company’s drug for “the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management,” commonly known as morning sickness.